| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.28 | 1e-06 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.26 | 1e-06 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.21 | 0.0001 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.21 | 0.0001 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.18 | 0.0001 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0006 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.18 | 0.0009 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |